Пошук по сайту
Авторизація
Логин:
Пароль:
Регистрация
Забыли свой пароль?
Періодика
Медична інформатика та інженерія
Партнери
Поиск информации по диагнозу / Med And Me Первый украинский нефрологический сайт проф. Д. Иванова Zepter
Технічна підтримка

Пристрої термічної абляції на ринку США (U.S. THERMAL ABLATION DEVICES MARKET)



В статті представлений аналіз продуктів, ринків пристроїв термічної абляції, конкурентів та нових препаратів, технологій і можливостей.

In the medical devices industry, the term "ablation"-primarily referring to radiofrequency or RF ablation-has become a common description attached to devices that "kill or remodel selective tissue without vaporizing the major structures themselves." Today, minimally invasive thermal ablation involves not only RF, but laser, microwave and high-intensity focused ultrasound (HIFU) technologies, and is commonly utilized in several established, growing, technology-driven medical treatment areas, such as benign prostatic hyperplasia (BPH), cancer/tumor ablation, endometrial ablation/menorrhagia, and the treatment of chronic venous insufficiency/varicose veins, as a cost-effective, efficacious alternative to surgery.

In addition to the lucrative (more than $730 million) and steadily growing U.S. thermal ablation medical devices market, nonsurgical energy-based (ablative) aesthetic devices, including laser/light-based and RF-based skin rejuvenation/tightening systems, as well as emerging HIFU and promising new nonsurgical fat reduction technologies such as cryolipolysis, are part of a significantly large, growing market benefiting from an aging population with a high discretionary income and willingness to invest in fast, effective, office-based aesthetic treatments with minimal down time. In 2011, the total estimated U.S. nonsurgical energy-based aesthetic devices market totaled more than $386 million.

Combined, the U.S. thermal ablation devices market-including generators,probes/applicators/instruments/disposables/accessories and service/procedure fees for the treatment areas defined in this report-totaled more than $1.1 billion in 2011. Despite current economic instability, each market segment profiled in this report is expected to increase at moderate to very healthy compound annual growth rates-ranging from 3.3%-17.7%-due to strong demand, cost-efficiency and efficacy, strong reimbursement, emerging unique, proprietary cost-effective, multi-platform next-generation technologies, and an aging population susceptible to various diseases/conditions.

This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging drugs, technology and opportunities. Covered products in this report include selected specialized energy-based generator systems, medical devices/instruments/accessories for the following minimally invasive or nonsurgical ablation treatment areas: BPH, cancer, chronic venous insufficiency/varicose veins, menorrhagia, and selected aesthetic areas, such as skin rejuvenation/skin tightening and body sculpting/cellulite/targeted fat reduction. Other applications include treatment of spinal denervation, stress urinary incontinence, and uterine fibroids.

EXECUTIVE SUMMARY

i. Overview of Thermal Ablation
ii. Thermal Ablation Medical Devices Market
iii. Nonsurgical Energy-Based Aesthetic Devices Market
iv. Methodology

Exhibit ES-1: Thermal Effects on Tissue
Exhibit ES-2: Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016
Exhibit ES-3: Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016
Exhibit ES-4: Nonsurgical Energy-Based Aesthetic Devices, Market Forecast, 2011-2016

1. THERMAL ABLATION DEVICES OVERVIEW

1.1 Applications for Thermal Ablation
1.1.1 Aesthetics-Skin Rejuvenation and Tightening
1.1.1.1 Alma Lasers
1.1.1.2 Cutera
1.1.1.3 Cynosure
1.1.1.4 Palomar Medical Technologies
1.1.1.5 Solta Medical
1.1.1.6 Syneron Medical
1.1.2 Aesthetics-Body Sculpting, Fat Reduction, and the Reduction in the Appearance of Cellulite
1.1.2.1 Cutera
1.1.2.2 Cynosure
1.1.2.3 Osyris Medical/LSO Medical
1.1.2.4 Solta Medical
1.1.2.5 Syneron Medical
1.1.2.6 Zeltiq Aesthetics
1.1.3 Benign Prostatic Hyperplasia
1.1.3.1 Transurethral Microwave Thermotherapy
1.1.3.1.1 American Medical Systems/Endo Health Solutions
1.1.3.1.2 Boston Scientific
1.1.3.1.3 ProstaLund Operations
1.1.3.1.4 Urologix
1.1.3.2 Transurethral Needle Ablation
1.1.3.3 Laser- and Other Energy-Based Therapies
1.1.3.3.1 Holmium Laser Ablation/Enucleation of the Prostate
1.1.3.3.1.1 Lumenis
1.1.3.3.2 Photoselective Vaporization ofthe Prostate
1.1.3.3.2.1 American Medical Systems/Endo Health Solutions
1.1.4 Cancer/Tumor Ablation
1.1.4.1 Radiofrequency Ablation
1.1.4.1.1 AngioDynamics
1.1.4.1.2 Boston Scientific
1.1.4.1.3 Celsion
1.1.4.1.4 Covidien
1.1.4.1.5 Thermedical
1.1.4.2 Other Ablation Methods
1.1.4.2.1 Cryoablation
1.1.4.2.1.1 Sanarus Technologies
1.1.4.2.2 Microwave Ablation
1.1.4.2.2.1 Covidien
1.1.4.2.2.2 Microsulis Medical and AngioDynamics
1.1.4.2.3 High-Intensity Focused Ultrasound
1.1.4.2.3.1 EDAP TMS
1.1.4.2.3.2 InSightec/Elbit Imaging
1.1.5 Menorrhagia/Endometrial Ablation
1.1.5.1 Boston Scientific
1.1.5.2 CooperSurgical/The Cooper Companies
1.1.5.3 Ethicon/Johnson & Johnson
1.1.5.4 Hologic
1.1.6 Spinal Decompression and Denervation
1.1.6.1 ArthroCare
1.1.6.2 Relievant Medsystems
1.1.6.3 Smith & Nephew
1.1.7 Stress Urinary Incontinence
1.1.7.1 Novasys Medical
1.1.8 Varicose Vein Ablation
1.1.8.1 AngioDynamics
1.1.8.2 CermaVEIN
1.1.8.3 Covidien
1.1.9 Uterine Fibroids
1.1.9.1 InSightec/Elbit Imaging
1.1.9.2 Philips Healthcare/Royal Philips Electronics
Exhibit 1-1: Thermal Effects on Tissue
Exhibit 1-2: The Accent Radiofrequency Platform
Exhibit 1-3: The Pixel CO2 Fractional Laser System and Technology
Exhibit 1-4: The Thermage CPT System
Exhibit 1-5: Sublative and Sublime Skin Rejuvenation Technologies
Exhibit 1-6: The TruSculpt Body Sculpting System
Exhibit 1-7: The Cellulaze Cellulite Laser Workstation
Exhibit 1-8: The Smartlipo LaserBodySculpting Workstations
Exhibit 1-9: The Lipocontrol GPS Laser Assisted Lipolysis System
Exhibit 1-10: A Step-by-Step LipoSonix Procedure
Exhibit 1-11: The VelaShape II System
Exhibit 1-12: The UltraShape Contour I Body Sculpting System
Exhibit 1-13: The CoolSculpting System and Step-by-Step Process
Exhibit 1-14: Advantages and Disadvantages of Minimally Invasive Therapy for Benign Prostatic Hyperplasia
Exhibit 1-15: The CoreTherm System
Exhibit 1-16: Five-Year Clinical Comparison of Symptomatic Reduction in Benign Prostatic Hyperplasia Using the CoreTherm System and Competitive Treatments
Exhibit 1-17: The CoolWave and Targis Systems
Exhibit 1-18: The Cooled ThermCath Advance Catheter
Exhibit 1-19: Cooled ThermoTherapy, Selected Five-Year Clinical Trial Results
Exhibit 1-20: Comparison of Cooled ThermoTherapy with Drug Therapy, Selected Clinical Results
Exhibit 1-21: The Prostiva Radiofrequency Therapy System
Exhibit 1-22: Holmium Laser Ablation of the Prostate Using the VersaPulse PowerSuite Laser System
Exhibit 1-23: Selected Advantages of Holmium Laser Ablation Using the VersaPulse PowerSuite Compared with Photoselective Vaporization Using the GreenLight PV
Exhibit 1-24: The GreenLight High Performance System
Exhibit 1-25: The GreenLight Xcelerated Performance System
Exhibit 1-26: The MoXy Liquid Cooled Fiber
Exhibit 1-27: The Model 1500X Electrosurgical Generator, and StarBurst Xli-Enhanced and Semi-Flex Electrodes
Exhibit 1-28: The StarBurst SDE and MRI Electrodes
Exhibit 1-29: The NanoKnife Low Energy Direct Current System and Electrode Probes
Exhibit 1-30: The RF 3000 Generator and LeVeen Needle Electrode
Exhibit 1-31: The Cool-tip RF Ablation System
Exhibit 1-32: The Cool-tip RF Ablation System E Series
Exhibit 1-33: The HALOFLEX System
Exhibit 1-34: The SERF Ablation System
Exhibit 1-35: The Visica 2 Treatment System and Step-by-Step Cryoablation Process
Exhibit 1-36: The Evident MWA System
Exhibit 1-37: The Acculis MTA System and Three-Step Procedure
Exhibit 1-38: The Ablatherm Robotic HIFU System
Exhibit 1-39: The ExAblate System
Exhibit 1-40: Breast Cancer Treatment Using the ExAblate System
Exhibit 1-41: The Three-Step Endometrial Ablation Process Using the Genesys HTA System
Exhibit 1-42: The Her Option Cryoablation System
Exhibit 1-43: The Gynecare ThermaChoice III Uterine Balloon Therapy System and a Comparison of Selected Outcome Data with Competitive Thermal Ablation Systems
Exhibit 1-44: The NovaSure System and Step-by-Step Endometrial Ablation Process
Exhibit 1-45: Selected Features of the Next-Generation NovaSure System
Exhibit 1-46: Nucleoplasty Using Coblation Technology
Exhibit 1-47: Intradiscal Electrothermal Therapy and Targeted Disc Decompression
Exhibit 1-48: Renessa Treatment for Stress Urinary Incontinence
Exhibit 1-49: The VenaCure EVLT System
Exhibit 1-50: The SVS System for the Treatment of Varicose Veins
Exhibit 1-51: The Venefit Targeted Endovenous Therapy System
Exhibit 1-52: Endovenous Ablation Using the Venefit System
Exhibit 1-53: Uterine Fibroid Treatment Using the ExAblate System
Exhibit 1-54: Sonalleve Therapy

2. THERMAL ABLATION DEVICES MARKET


2.1 Procedure Volumes
2.2 Market Forecast
2.3 Competitive Analysis
2.3.1 Benign Prostatic Hyperplasia Ablation
2.3.2 Cancer/Tumor Ablation
2.3.3 Endometrial Ablation
2.3.4 Endovenous Ablation
2.4 Other Ablation Markets
2.4.1 Aesthetics
2.4.1.1 Procedure Volumes
2.4.1.2 Market Forecast
2.4.1.3 Competitive Analysis
2.4.1.4 Nonsurgical Body Sculpting/Fat Reduction
2.4.2 Spinal Disc Decompression and Denervation
Exhibit 2-1: Thermal Ablation, Procedure Volumes Forecast, by Type, 2011-2016
Exhibit 2-2: Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016
Exhibit 2-3: Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016
Exhibit 2-4: 2011, Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment
Exhibit 2-5: 2016, Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment
Exhibit 2-6: 2011, Benign Prostatic Hyperplasia Laser Ablation Products Market, Share by Supplier
Exhibit 2-7: 2011, Benign Prostatic Hyperplasia Microwave and Radiofrequency Ablation Products Market, Share by Supplier
Exhibit 2-8: 2011, Tumor Ablation Products Market, Share by Supplier
Exhibit 2-9: 2011, Endometrial Ablation Products Market, Share by Supplier
Exhibit 2-10: 2011, Endovenous Ablation Products Market, Share by Supplier
Exhibit 2-11: 2010 and 2011, Selected Aesthetic Procedures and Average Physician Fees
Exhibit 2-12: 2011, Top 5 Surgical Aesthetic Procedures
Exhibit 2-13: 2011, Top 5 Nonsurgical Aesthetic Procedures
Exhibit 2-14: Selected Nonsurgical Energy-Based Aesthetic Treatments, Procedure Volumes Forecast, 2011-2016
Exhibit 2-15: Nonsurgical Energy-Based Aesthetic Devices, Market Forecast, 2011-2016
Exhibit 2-16: Leading Nonsurgical Energy-Based Aesthetic Device Companies, Global Revenues, 2010-2011
Exhibit 2-17: 2011, Global Nonsurgical Energy-Based Aesthetic Devices Market, Share by Supplier
Exhibit 2-18: 2011, U.S. Nonsurgical Energy-Based Aesthetic Devices Market, Share by Supplier
Exhibit 2-19: 2012, Selected Nonsurgical Energy-Based Body Sculpting/Fat Reduction Systems

3. COMPANY PROFILES

3.1 AngioDynamics, Inc.
3.2 Boston Scientific Corporation
3.3 Covidien PLC
3.4 Endo Health Solutions, Inc.
3.5 Hologic, Inc.
3.6 InSightec LTD/Elbit Imaging LTD
3.7 Johnson & Johnson
3.8 Microsulis Medical LTD
3.9 Solta Medical, Inc.
3.10 Syneron Medical LTD
3.11 Zeltiq Aesthetics, Inc.

APPENDIX: COMPANY LISTING

Alma Lasers LTD
American Medical Systems, Inc./ Endo Health Solutions, Inc.
AngioDynamics, Inc.
ArthroCare Corporation
Boston Scientific Corporation
Celsion Corporation
CermaVEIN S.A.S.
CooperSurgical, Inc./ The Cooper Companies, Inc.
Covidien PLC
Cutera, Inc.
Cynosure, Inc.
EDAP TMS S.A.
Endo Health Solutions, Inc.
Ethicon Endo-Surgery, Inc./ Johnson & Johnson
Ethicon, Inc./ Johnson & Johnson
Hologic, Inc.
InSightec LTD/Elbit Imaging LTD
Johnson & Johnson
Lumenis LTD
Medtronic, Inc.
Microsulis Medical LTD
Novasys Medical, Inc.
Osyris Medical/LSO Medical
Palomar Medical Technologies, Inc.
Philips Healthcare/ Royal Philips Electronics NV
ProstaLund Operations AB
Relievant Medsystems, Inc.
Sanarus Technologies LLC
Smith & Nephew PLC
Solta Medical, Inc.
Syneron Medical LTD
Thermedical, Inc.
Urologix, Inc.
Zeltiq Aesthetics, Inc.
Publisher: Medtech Insight
Перекладач: translate.google.com
Новини
03.03.2023  Науково доведено: через смартфони ви можете старіти швидше
24.02.2023  Стимуляція спинного мозку відновлює постінсультну функцію рук
17.02.2023  Вчені відкрили здатність жирної їжі руйнувати мозок
10.02.2023  В Індії розробили неінвазивний тест, який використовує штучний інтелект для виявлення раку молочної залози
01.02.2023  Як спостереження за світанками та заходами сонця впливає на здоров'я – вчені
25.01.2023  Аналіз крові для ранньої діагностики хвороби Альцгеймера розробили вчені
18.01.2023  Людина з серцем свині. Пацієнту вперше пересадили серце тварини
11.01.2023  Вчені пояснили, чому оливкову олію варто пити ложками
21.11.2022  Вчені виявили ще одну причину високого ризику атеросклерозу
18.11.2022  Імплантована помпа доставила протиракові ліки у пухлини мозку
16.11.2022  Шум вночі може бути причиною безсоння та серцево-судинних захворювань
14.11.2022  ЩО ТРЕБА ЗНАТИ ПРО ЦУКРОВИЙ ДІАБЕТ: ТИПИ, СИМПТОМИ, УСКЛАДНЕННЯ
11.11.2022  Виявилося, в епідемії ожиріння винен лише один тип їжі
09.11.2022  Проказа: давня хвороба, здатна регенерувати органи
07.11.2022  "Чарівні гриби" можуть лікувати важку депресію
04.11.2022  Нове випробування пропонує переваги CV з EPA: RESPECT-EPA
02.11.2022  Майже 500 українських медиків завершили навчання з тактичної медицини
01.11.2022  Чи можна людям з діабетом пити алкоголь
31.10.2022  Знайдено овоч, здатний знизити цукор у крові відразу на 20%
28.10.2022  Людська печінка може працювати 100 років
HINARI
PubMed